首页|Researchers Submit Patent Application, 'Method And System For Determining Differential Diagnosis Using A Multi-Classifier Learning Model', for Approval (USPTO 20240038392)
Researchers Submit Patent Application, 'Method And System For Determining Differential Diagnosis Using A Multi-Classifier Learning Model', for Approval (USPTO 20240038392)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
From Washington, D.C., NewsRx journalists report that a patent application by the inventors SHAPIRA, Chen (Haifa, IL); UZIEL, Shlomi (Neve Ilan, IL); YONA, Golan (Tel Aviv, IL), filed on July 31, 2023, was made available online on February 1, 2024. The patent's assignee is Quai.MD Ltd. (Neve Ilan, Israel). News editors obtained the following quote from the background information supplied by the inventors: "Clinical pathway is a tool to guide evidence-based healthcare for clinical problems with a goal of providing organized and standardized healthcare processes. The clinical pathway facilitates the decision-making process for physicians by providing a step-by-step guidance to improve patient safety and clinical efficiency. To this end, adherence to such pathways provides advantages of improving patient outcomes, reducing variations in diagnoses, costs, and more. "However, currently developed clinical pathways are isolated protocols that often focus on a single diagnosis or disease group. Such isolation and limitation do not reflect the complex, dynamic interconnections of diseases and the human body, and can cause inaccurate decisions. As an example, chest pain is a common complaint associated with up to 30 diseases where some are more frequent and easier to diagnose, but others are rare and may be more complicated to diagnose.
BusinessCyborgsEmerging TechnologiesHospitalsMachine LearningQuaiMD LtdRisk and Prevention
NETL
NSTL
